Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

US Pharmaceuticals Ishares ETF (NY: IHE )

67.31 +0.40 (+0.60%)
Streaming Delayed Price Updated: 2:03 PM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,094
Open 66.97
Bid (Size) 67.28 (1)
Ask (Size) 67.30 (3)
Prev. Close 66.91
Today's Range 66.94 - 67.33
52wk Range 62.67 - 208.68
Shares Outstanding 96,000
Dividend Yield 5.36%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look At Pharma ETFs Post Q1 Earnings
Pharma ETFs have delivered mixed performances over the past month. 
Via Talk Markets
Topics ETFs
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest... 
Via Talk Markets
Topics ETFs

Performance

YTD
-64.15%
-64.15%
1 Month
+0.34%
+0.34%
3 Month
+2.06%
+2.06%
6 Month
-64.94%
-64.94%
1 Year
-61.42%
-61.42%

More News

Read More
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Via Benzinga
Topics Stocks
Exposures US Equities
3 Sector ETFs That Beat The Market Last Week
Via Talk Markets
Topics ETFs
US Pharmaceuticals: A Bifurcated Market
Via Talk Markets
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
Via Benzinga
A Look At Pharma ETFs After Q4 Earnings
Via Talk Markets
Topics ETFs
Bank Of America Predicts 10 2024 Market Surprises: From Booming IPOs To Japanese Equity Surge
Via Benzinga
Topics Bonds
Exposures Debt Markets
3 Beaten-Down ETFs To Buy For A Turnaround In 2024
Via Talk Markets
Topics ETFs
Exposures COVID-19
5 Secret Santa ETFs That Might Surprise You This Christmas
Via Talk Markets
Topics ETFs
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
Via Benzinga
5 Sector ETFs That Outperformed in Turbulent August
Via Talk Markets
Topics ETFs
Q2 Earnings & Market Sell-Off Impact: 5 Must-See ETF Charts
Via Talk Markets
Topics ETFs
Pharma ETFs in Focus Post Q2 Earnings
Via Talk Markets
Topics ETFs
3 Biotech Stocks to Sell in June Before They Crash and Burn
Via InvestorPlace
Pharma ETFs Gain Post Q1 Earnings
Via Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
Via Talk Markets
4 Sector ETFs To Watch Ahead Of Mid-Election Results
Via Talk Markets
5 ETFs To Watch After 2022 Midterm Elections: Which Sectors Win From Republican Or Democrat Majority?
Via Benzinga
Pharma ETFs In Focus Post Q3 Earnings
Via Talk Markets
ETF Mid-Year Outlook & Investing Strategies
Via Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
Via Talk Markets
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
Via Talk Markets
Exposures COVID-19
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
Via Talk Markets
Exposures COVID-19 Product Safety
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
Via Talk Markets
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.